David MacPherson

6.5k citations

48 papers · 4.3k indexed · 2 hit papers · h-index 31

Impact in

Oncology top 1%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Cancer Research top 2%

Papers in ⓘ

Oncology 43
- Lung Cancer Research Studies 21
- Cancer-related Molecular Pathways 14
- Peptidase Inhibition and Analysis 7
- Ear and Head Tumors 4
Ophthalmology 7
- Ocular Oncology and Treatments 7

Co-authors: Tak W. Mak (3 shared papers)Vuk Stambolic (2 shared papers)Julien Sage (6 shared papers)Brian J. Snow (1 shared paper)Samuel Benchimol (1 shared paper)Yunping Lin (1 shared paper)Tyler Jacks (7 shared papers)Adi F. Gazdar (6 shared papers)
Journals: Genes & Development (5 papers)Journal of Thoracic Oncology (3 papers)British Journal of Oral and Maxillofacial Surgery (3 papers)Science Advances (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

David MacPherson

44 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data 2019 · 718 citations

Peers

Countries citing papers authored by David MacPherson

Since Specialization

Citations

This map shows the geographic impact of David MacPherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David MacPherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David MacPherson more than expected).

Fields of papers citing papers by David MacPherson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David MacPherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David MacPherson. The network helps show where David MacPherson may publish in the future.

Co-authors

The 25 scholars most cited alongside David MacPherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David MacPherson Line = papers co-authored together David MacPherson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Regulation of PTEN Transcription by p53 Molecular Cell ·Vuk Stambolic, David MacPherson, D. Sas, Yunping Lin, Brian J. Snow, YingJu Jang, Samuel Benchimol, Tak W. Mak Hit paper breakdown →	2001	753
2	Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data Nature reviews. Cancer ·Charles M. Rudin, John T. Poirier, Lauren A. Byers, Caroline Dive, Afshin Dowlati, Julie George, John V. Heymach, Jane E. Johnson, Jonathan M. Lehman, David MacPherson, Pierre P. Massion, John D. Minna, Trudy G. Oliver, Vito Quaranta, Julien Sage, Roman K. Thomas, Christopher R. Vakoc, Adi F. Gazdar Hit paper breakdown →	2019	718
3	High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. PubMed ·Vuk Stambolic, Ming‐Sound Tsao, David MacPherson, Akira Suzuki, William Chapman, Tak W. Mak	2000	301
4	Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex Cell Death and Differentiation ·Dita Rasper, John P. Vaillancourt, (unknown), Vicky M. Houtzager, Isolde M. Seiden, Sabina Keen, Paul Tawa, Steve Xanthoudakis, Jamal Nasir, Duane W. Martindale, Ben F. Koop, Erin P. Peterson, Nancy A. Thornberry, Jing-Qi Huang, David MacPherson, Shawn C. Black, Felicita Hornung, Michael J. Lenardo, Michael R. Hayden, Sophie Roy, Donald W. Nicholson	1998	271
5	Cell type-specific effects of Rb deletion in the murine retina Genes & Development ·David MacPherson, Julien Sage, Teresa S. Kim, Dennis M. Ho, Margaret E. McLaughlin, Tyler Jacks	2004	176
6	Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition Science Signaling ·Arnaud Augert, Emily Eastwood, Ali H. Ibrahim, Nan Wu, Eli Grunblatt, Ryan Basom, Denny Liggitt, Keith D. Eaton, Renato Martins, John T. Poirier, Charles M. Rudin, Francesca Milletti, Wei‐Yi Cheng, Fiona Mack, David MacPherson	2019	154
7	miR-17∼92 cooperates with RB pathway mutations to promote retinoblastoma Genes & Development ·Karina L. Conkrite, Maggie Sundby, Shizuo Mukai, J. Michael Thomson, David Mu, Scott M. Hammond, David MacPherson	2011	145
8	p53 Accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101 Proceedings of the National Academy of Sciences ·Jürgen Ruland, Christian Sirard, Andrew Elia, David MacPherson, Andrew Wakeham, Limin Li, José Luís de la Pompa, Stanley N. Cohen, Tak W. Mak	2001	126
9	Conditional Mutation of Rb Causes Cell Cycle Defects without Apoptosis in the Central Nervous System Molecular and Cellular Biology ·David MacPherson, Julien Sage, Denise Crowley, Andreas Trumpp, Roderick T. Bronson, Tyler Jacks	2003	119
10	Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition Cancer Discovery ·Deshui Jia, Arnaud Augert, Dong Wook Kim, Emily Eastwood, Nan Wu, Ali H. Ibrahim, Kee‐Beom Kim, Colin T. Dunn, Smitha P.S. Pillai, Adi F. Gazdar, Hamid Bolouri, (unknown), David MacPherson	2018	115
11	Lung Cancer Subtypes Generate Unique Immune Responses The Journal of Immunology ·Stephanie Busch, Mark L. Hanke, Julia Kargl, Heather Metz, David MacPherson, A. McGarry Houghton	2016	114
12	PTEN Is a Potent Suppressor of Small Cell Lung Cancer Molecular Cancer Research ·Min Cui, Arnaud Augert, Michael Rongione, Karina L. Conkrite, Susan Parazzoli, Alexander Yu. Nikitin, Nicholas T. Ingolia, David MacPherson	2014	98
13	Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23 The EMBO Journal ·David MacPherson, Jungho Kim, Teresa S. Kim, Byung Kirl Rhee, Conny Th.M. van Oostrom, Richard A. DiTullio, Monica Venere, Thanos D. Halazonetis, Roderick T. Bronson, Annemieke de Vries, Mark D. Fleming, Tyler Jacks	2004	94
14	The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung Journal of Thoracic Oncology ·Adi F. Gazdar, Trisha K. Savage, Jane E. Johnson, Anton Berns, Julien Sage, R. Ilona Linnoila, David MacPherson, David G. McFadden, Anna F. Farago, Tyler Jacks, William D. Travis, Élisabeth Brambilla	2015	84
15	Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance) Journal of Thoracic Oncology ·Arnaud Augert, ZhongXiang Zhang, Breanna M. Bates, Min Cui, Xiaofei Wang, Gary Wildey, Afshin Dowlati, David MacPherson	2016	73
16	Genetic requirement forMycland efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer Genes & Development ·Dong Wook Kim, Nan Wu, Young‐Chul Kim, Pei Cheng, Ryan Basom, Dongkyoon Kim, Colin T. Dunn, Anastasia Y. Lee, Kee‐Beom Kim, Chang Sup Lee, Andrew Singh, Adi F. Gazdar, Chris Harris, Robert N. Eisenman, (unknown), David MacPherson	2016	72
17	Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing Clinical Cancer Research ·Joseph B. Hiatt, Holly Sandborg, Sarah M. Garrison, Henry U. Arnold, Sheng-You Liao, Justin P. Norton, Travis J. Friesen, Feinan Wu, (unknown), Hugh Young Rienhoff, Renato Martins, A. McGarry Houghton, Shivani Srivastava, David MacPherson	2022	68
18	MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity Genes & Development ·Eli Grunblatt, Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P. Norton, Yamini M. Ohol, Paul R. Leger, Joseph B. Hiatt, Emily Eastwood, Rhiana Thomas, Ali H. Ibrahim, Deshui Jia, Ryan Basom, Keith D. Eaton, Renato Martins, A. McGarry Houghton, David MacPherson	2020	68
19	Surgical management of incompletely excised basal cell carcinomas of the head and neck British Journal of Oral and Maxillofacial Surgery ·A. Wilson, Geoffrey Howsam, Vijay Santhanam, David MacPherson, Jerry Grant, C.A. Pratt, John Townend	2004	59
20	Murine bilateral retinoblastoma exhibiting rapid‐onset, metastatic progression and N‐myc gene amplification The EMBO Journal ·David MacPherson, Karina L. Conkrite, Mandy Tam, Shizuo Mukai, David Mu, Tyler Jacks	2007	54

About David MacPherson

David MacPherson is a scholar working on Oncology, Ophthalmology, Cancer Research, Epidemiology and Molecular Biology, having authored 48 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (21 papers), Cancer-related Molecular Pathways (14 papers), Neuroendocrine Tumor Research Advances (14 papers), Ocular Oncology and Treatments (7 papers), Peptidase Inhibition and Analysis (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer therapeutics and mechanisms (4 papers) and Ear and Head Tumors (4 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (693 citations), Molecular Biology (2.7k citations), Ophthalmology (289 citations) and Epidemiology (1.0k citations). David MacPherson has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Tak W. Mak, Vuk Stambolic, Julien Sage, Brian J. Snow, Samuel Benchimol, Yunping Lin, Tyler Jacks, Adi F. Gazdar, Afshin Dowlati and Charles M. Rudin. Their work appears in journals such as Genes & Development, Journal of Thoracic Oncology, British Journal of Oral and Maxillofacial Surgery, Science Advances and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact